EMILY HARRIS: Open Payments
NPI 1821638842 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 83 payments from 22 companies in 2025. Trend: 2023 $753 · 2024 $1,454 · 2025 $2,083
Food & beverage: $1,983Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $378 |
| GlaxoSmithKline, LLC. | 15 | $284 |
| Verona Pharma, Inc. | 5 | $189 |
| Actelion Pharmaceuticals US, Inc. | 4 | $168 |
| Regeneron Healthcare Solutions, Inc. | 7 | $165 |
| Merck Sharp & Dohme LLC | 3 | $149 |
| GENZYME CORPORATION | 4 | $98 |
| United Therapeutics Corporation | 3 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
Products named: NUCALA, DUPIXENT, Ohtuvayre, OPSUMIT, WINREVAIR, BREZTRI, FASENRA, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
